Visualization of a neurotropic flavivirus infection in mouse reveals unique viscerotropism controlled by host type I interferon signaling

Theranostics

Volumn 7, Issue 4, 2017, Pages 912-925

  Li, Xiao Feng ^a   Li, Xiao Dan ^b   Deng, Cheng Lin ^b   Dong, Hao Long ^a   Zhang, Qiu Yan ^b   Ye, Qing ^a   Ye, Han Qing ^b   Huang, Xing Yao ^a   Deng, Yong Qiang ^a   Zhang, Bo ^b   Qin, Cheng Feng ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

Bioluminescence imaging; Flavivirus; Interferon signaling; Japanese encephalitis virus; Mouse

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; INTERFERON RECEPTOR; JAPANESE ENCEPHALITIS VACCINE; NITD 008; RIBAVIRIN; UNCLASSIFIED DRUG; RENILLA LUCIFERIN 2 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; IC90; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; KIDNEY; LIVER; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; SPLEEN; VACCINATION; VIRAL TROPISM; VIRUS REPLICATION; VIRUS VIRULENCE; ANIMAL; ANIMAL STRUCTURES; CELL LINE; DISEASE MODEL; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUMINESCENCE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REPORTER GENE; STAINING; VIROLOGY;

ANIMAL STRUCTURES; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DISEASE MODELS, ANIMAL; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; GENES, REPORTER; HOST-PATHOGEN INTERACTIONS; INTERFERON TYPE I; LUCIFERASES, RENILLA; LUMINESCENT MEASUREMENTS; MICE; SIGNAL TRANSDUCTION; STAINING AND LABELING; VIRAL TROPISM;

EID: 85014506803     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.16615     Document Type: Article

References (61)

1. Peltier DC, Lazear HM, Farmer JR, Diamond MS, Miller DJ. Neurotropic arboviruses induce interferon regulatory factor 3-mediated neuronal responses that are cytoprotective, interferon independent, and inhibited by Western equine encephalitis virus capsid. Journal of virology. 2013; 87: 1821-33.
2. Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bulletin of the World Health Organization. 2011; 89: 766-74, 74A-74E.
3. Ghosh D, Basu A. Japanese encephalitis-a pathological and clinical perspective. PLoS neglected tropical diseases. 2009; 3: e437.
4. Le Flohic G, Porphyre V, Barbazan P, Gonzalez JP. Review of climate, landscape, and viral genetics as drivers of the Japanese encephalitis virus ecology. PLoS neglected tropical diseases. 2013; 7: e2208.
5. Solomon T. Control of Japanese encephalitis--within our grasp? The New England journal of medicine. 2006; 355: 869-71.
6. Mackenzie JS, Johansen CA, Ritchie SA, van den Hurk AF, Hall RA. Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australasia. Current topics in microbiology and immunology. 2002; 267: 49-73.
7. Igarashi A, Tanaka M, Morita K, Takasu T, Ahmed A, Ahmed A, et al. Detection of west Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan. Microbiology and immunology. 1994; 38: 827-30.
8. Paul WS, Moore PS, Karabatsos N, Flood SP, Yamada S, Jackson T, et al. Outbreak of Japanese encephalitis on the island of Saipan, 1990. The Journal of infectious diseases. 1993; 167: 1053-8.
9. Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nature medicine. 2004; 10: S98-109.
10. [Internet] CDC. West Nile virus disease cases and deaths reported to CDC by year and clinical presentation, 1999-2014. http://www.cdc.gov/westnile/ statsmaps/cummapsdata.html.
11. Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika Virus. N Engl J Med. 2016; 374: 1552-63.
12. Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika Virus and Birth Defects--Reviewing the Evidence for Causality. N Engl J Med. 2016; 374: 1981-7.
13. Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT. Japanese encephalitis. Journal of neurology, neurosurgery, and psychiatry. 2000; 68: 405-15.
14. Solomon T, Kneen R, Dung NM, Khanh VC, Thuy TT, Ha DQ, et al. Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet. 1998; 351: 1094-7.
15. Welte T, Reagan K, Fang H, Machain-Williams C, Zheng X, Mendell N, et al. Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection. The Journal of general virology. 2009; 90: 2660-8.
16. Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, et al. Human skin Langerhans cells are targets of dengue virus infection. Nature medicine. 2000; 6: 816-20.
17. Lim PY, Behr MJ, Chadwick CM, Shi PY, Bernard KA. Keratinocytes are cell targets of West Nile virus in vivo. Journal of virology. 2011; 85: 5197-201.
18. Samuel MA, Diamond MS. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. Journal of virology. 2006; 80: 9349-60.
19. Dumpis U, Crook D, Oksi J. Tick-borne encephalitis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1999; 28: 882-90.
20. Mathur A, Arora KL, Chaturvedi UC. Congenital infection of mice with Japanese encephalitis virus. Infection and immunity. 1981; 34: 26-9.
21. Mathur A, Kulshreshtha R, Chaturvedi UC. Evidence for latency of Japanese encephalitis virus in T lymphocytes. The Journal of general virology. 1989; 70 ( Pt 2): 461-5.
22. Huang CH, and Wong C. Relation of the peripheral multiplication of Japanese B encephalitis virus to the pathogenesis of the infection in mice. Acta Virol. 1963; 7(16): 322-30.
23. Lee E, Hall RA, Lobigs M. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. Journal of virology. 2004; 78: 8271-80.
24. Lee E, Lobigs M. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. Journal of virology. 2002; 76: 4901-11.
25. Andreu N, Zelmer A, Wiles S. Noninvasive biophotonic imaging for studies of infectious disease. FEMS microbiology reviews. 2011; 35: 360-94.
26. Chang MH, Cirillo SL, Cirillo JD. Using luciferase to image bacterial infections in mice. Journal of visualized experiments: JoVE. 2011.
27. Harmache A, LeBerre M, Droineau S, Giovannini M, Bremont M. Bioluminescence imaging of live infected salmonids reveals that the fin bases are the major portal of entry for Novirhabdovirus. Journal of virology. 2006; 80: 3655-9.
28. Hutchens M, Luker GD. Applications of bioluminescence imaging to the study of infectious diseases. Cellular microbiology. 2007; 9: 2315-22.
29. Luker GD, Bardill JP, Prior JL, Pica CM, Piwnica-Worms D, Leib DA. Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. Journal of virology. 2002; 76: 12149-61.
30. Mandl S, Schimmelpfennig C, Edinger M, Negrin RS, Contag CH. Understanding immune cell trafficking patterns via in vivo bioluminescence imaging. Journal of cellular biochemistry Supplement. 2002; 39: 239-48.
31. Luker KE, Hutchens M, Schultz T, Pekosz A, Luker GD. Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread. Virology. 2005; 341: 284-300.
32. Pan W, Dong Z, Li F, Meng W, Feng L, Niu X, et al. Visualizing influenza virus infection in living mice. Nature communications. 2013; 4: 2369.
33. Rameix-Welti MA, Le Goffic R, Herve PL, Sourimant J, Remot A, Riffault S, et al. Visualizing the replication of respiratory syncytial virus in cells and in living mice. Nature communications. 2014; 5: 5104.
34. Wang L, Fu Q, Dong Y, Zhou Y, Jia S, Du J, et al. Bioluminescence imaging of Hepatitis C virus NS3/4A serine protease activity in cells and living animals. Antiviral research. 2010; 87: 50-6.
35. Zaitseva M, Kapnick SM, Scott J, King LR, Manischewitz J, Sirota L, et al. Application of bioluminescence imaging to the prediction of lethality in vaccinia virus-infected mice. Journal of virology. 2009; 83: 10437-47.
36. Li XF, Deng YQ, Zhao H, Ye Q, Wang HJ, Li SH, et al. Noninvasive bioluminescence imaging of dengue virus infection in the brain of A129 mice. Applied microbiology and biotechnology. 2013; 97: 4589-96.
37. Schoggins JW, Dorner M, Feulner M, Imanaka N, Murphy MY, Ploss A, et al. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109: 14610-5.
38. Li XD, Li XF, Ye HQ, Deng CL, Ye Q, Shan C, et al. Recovery of a chemically synthesized Japanese encephalitis virus reveals two critical adaptive mutations in NS2B and NS4A. The Journal of general virology. 2014; 95: 806-15.
39. Tilgner M, Shi PY. Structure and function of the 3' terminal six nucleotides of the west nile virus genome in viral replication. J Virol. 2004; 78: 8159-71.
40. Yin Z, Chen YL, Schul W, Wang QY, Gu F, Duraiswamy J, et al. An adenosine nucleoside inhibitor of dengue virus. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106: 20435-9.
41. Li XF, Dong HL, Huang XY, Qiu YF, Wang HJ, Deng YQ, et al. Characterization of a 2016 Clinical Isolate of Zika Virus in Non-human Primates. EBioMedicine. 2016; 12: 170-7.
42. Zhang PT, Shan C, Li XD, Liu SQ, Deng CL, Ye HQ, et al. Generation of a recombinant West Nile virus stably expressing the Gaussia luciferase for neutralization assay. Virus Res. 2016; 211: 17-24.
43. Leyssen P, Balzarini J, De Clercq E, Neyts J. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. Journal of virology. 2005; 79: 1943-7.
44. Benarroch D, Egloff MP, Mulard L, Guerreiro C, Romette JL, Canard B. A structural basis for the inhibition of the NS5 dengue virus mRNA 2'-O-methyltransferase domain by ribavirin 5'-triphosphate. The Journal of biological chemistry. 2004; 279: 35638-43.
45. Zou G, Xu HY, Qing M, Wang QY, Shi PY. Development and characterization of a stable luciferase dengue virus for high-throughput screening. Antiviral research. 2011; 91: 11-9.
46. Filomatori CV, Lodeiro MF, Alvarez DE, Samsa MM, Pietrasanta L, Gamarnik AV. A 5' RNA element promotes dengue virus RNA synthesis on a circular genome. Genes & development. 2006; 20: 2238-49.
47. Clyde K, Harris E. RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J Virol. 2006; 80: 2170-82.
48. Liu ZY, Li XF, Jiang T, Deng YQ, Zhao H, Wang HJ, et al. Novel cis-acting element within the capsid-coding region enhances flavivirus viral-RNA replication by regulating genome cyclization. Journal of virology. 2013; 87: 6804-18.
49. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, Garcia-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107: 11531-6.
50. Tokusumi T, Iida A, Hirata T, Kato A, Nagai Y, Hasegawa M. Recombinant Sendai viruses expressing different levels of a foreign reporter gene. Virus research. 2002; 86: 33-8.
51. Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. Journal of virology. 2004; 78: 2701-10.
52. Lobigs M, Mullbacher A, Wang Y, Pavy M, Lee E. Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus. The Journal of general virology. 2003; 84: 567-72.
53. Samuel MA, Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. Journal of virology. 2005; 79: 13350-61.
54. Ryman KD, Klimstra WB, Nguyen KB, Biron CA, Johnston RE. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. Journal of virology. 2000; 74: 3366-78.
55. Zellweger RM, Prestwood TR, Shresta S. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell host & microbe. 2010; 7: 128-39.
56. Solomon T, Vaughn DW. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol. 2002; 267: 171-94.
57. Martin M, Tsai TF, Cropp B, Chang GJ, Holmes DA, Tseng J, et al. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet. 2001; 358: 98-104.
58. Centers for Disease C Prevention. Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001-2002. MMWR Morb Mortal Wkly Rep. 2002; 51: 989-93.
59. Vasconcelos PF, Luna EJ, Galler R, Silva LJ, Coimbra TL, Barros VL, et al. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet. 2001; 358: 91-7.
60. Chan RC, Penney DJ, Little D, Carter IW, Roberts JA, Rawlinson WD. Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet. 2001; 358: 121-2.
61. Shan C, Xie X, Muruato AE, Rossi SL, Roundy CM, Azar SR, et al. An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors. Cell Host Microbe. 2016; 19: 891-900.